Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Japan radiotherapy patient positioning accessories market was valued at USD 29.36 Million in 2025 driven by its advanced oncology infrastructure, integration of imaging technologies, and strong focus on treatment precision across the region. It is expected to grow at a CAGR of 4.00% during the forecast period of 2026-2035 and attain a market value of USD 43.46 Million by 2035. As radiotherapy becomes more targeted, demand for high-performance positioning systems will continue to grow, supporting innovation and improved patient outcomes across Japan’s healthcare ecosystem.
Base Year
Historical Period
Forecast Period
High incidence of lung and gastrointestinal cancers is accelerating the need for advanced positioning accessories in radiotherapy delivery.
Japan’s focus on proton therapy and IMRT drives demand for precise immobilization systems to enhance treatment accuracy.
Aging population and early-stage cancer detection trends are supporting increased use of patient-specific positioning accessories in radiotherapy planning.
Compound Annual Growth Rate
4%
Value in USD Million
2026-2035
*this image is indicative*
Radiotherapy patient positioning accessories are crucial in ensuring consistent body alignment for the accurate delivery of radiation therapy. These tools support the effectiveness of treatments by minimizing movement and ensuring precise targeting of tumors. In Japan, they play a particularly important role in managing lung cancer, one of the country’s leading causes of cancer-related deaths. Given the complexities of thoracic anatomy and respiratory motion, these accessories enable more controlled and effective radiotherapy for better clinical outcomes.
Innovational Rollouts in Japan Propel Positioning Accessories Demand
In November 2023, Accuray began sales of its VitalHold™ solution in Japan, integrating surface-guided radiation therapy (SGRT) with Radixact systems, enabling markerless patient setup and deep inspiration breath-hold (DIBH) treatments. This strategic launch meets growing clinical demand for precise, non-invasive positioning accessories, accelerating adoption across Japanese radiotherapy centers and reinforcing the country’s market growth trajectory.
The market is expanding due to rising cancer cases and advanced technology integration.
Rising Cancer Burden in Japan Bolsters Market Growth
According to GLOBOCAN 2022, Japan recorded 2,741,718 five‑year prevalent cancer cases, with 240,823 deaths and an age‑standardized mortality rate of 100.7 per 100,000. This substantial cancer burden is driving hospitals to invest in advanced radiotherapy technology and patient positioning accessories. As precision treatment becomes increasingly essential to improve outcomes and manage high caseloads, demand for reliable positioning systems is rising steadily across Japan’s oncology infrastructure.
Cancer Therapy Leading the Segment by Application
Cancer therapy is projected to dominate the market, driven by Japan’s growing aging population and high cancer incidence, over 1 million new cases reported in 2022, with colorectal (145,756 cases, 14.5%), lung (136,723 cases, 13.6%), and stomach cancer (126,724 cases, 12.6%) leading. These therapies require accurate targeting, and positioning accessories play a vital role. Japan’s advanced oncology infrastructure, with eight times more MRI scanners per capita than Europe, alongside widespread use of image-guided and intensity-modulated radiation therapy (IMRT), further amplifies demand for high-performance positioning tools tailored to complex treatment needs.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Hitachi Ltd., founded in 1910 and headquartered in Tokyo, Japan, is a multinational conglomerate with a strong presence in healthcare technologies. In Japan’s radiotherapy patient positioning accessories market, Hitachi supports precision oncology through its advanced proton therapy systems and integrated positioning solutions. These technologies are crucial in minimizing radiation exposure to surrounding tissues, especially in pediatric and complex cancers. Hitachi’s commitment to innovation and safety strengthens Japan’s position in delivering advanced, patient-centered cancer care.
Established in 1875 and headquartered in Kyoto, Japan, Shimadzu Corporation is a key player in imaging and diagnostic solutions. In Japan’s radiotherapy patient positioning accessories market, it offers high-resolution imaging systems that integrate seamlessly with immobilization and alignment tools. These systems are crucial in supporting precision-guided therapies, especially in high-incidence cancers like lung and GI cancers. Shimadzu’s deep-rooted presence in Japanese healthcare ensures continuous technological advancement and reliability in radiation oncology settings.
CDR Systems, headquartered in Calgary, Canada, and founded in 2001, delivers globally recognized radiotherapy positioning solutions. In Japan, where precision in radiation delivery is paramount, CDR’s advanced immobilization systems, such as vacuum cushions, overlays, and head-and-neck supports, are widely adopted. Their compatibility with MR and CT platforms aids accurate planning and setup, which is critical in complex treatments like stereotactic body radiation therapy (SBRT). CDR’s focus on innovation and patient safety aligns with Japan’s stringent clinical standards.
Orfit Industries, based in Belgium and founded in 1991, is a leading provider of thermoplastic masks and immobilization accessories used in radiotherapy. In Japan, Orfit’s patient-centric solutions support advanced techniques such as IMRT and proton therapy, offering high precision in positioning for head, neck, and breast cancer patients. The company’s products are known for customization and reproducibility, which are essential in Japan’s oncology landscape that emphasizes minimal error margins and optimal patient outcomes.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Best Medical International Inc., CIVCO Medical Solutions, and MacroMedics BV.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Market Breakup by Application
Market Breakup by End User
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share